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Display cloning: functional identification of natural product
receptors using cDNA-phage display
Paul P Sche, Kathleen M McKenzie, Jennifer D White and David J Austin
Background: The identification of cellular targets has traditionally been the
starting point for natural product mode of action studies and has led to the
understanding of many biological processes. Conventional experimental
approaches have depended on cell-based screening and/or affinity
chromatography. Although both of these techniques aid in the discovery of
protein cellular targets, a method that couples protein identification with gene
isolation would be extremely valuable.
Results: A procedure for the direct cloning of cellular proteins, based on their
affinity for natural products, using cDNA phage display has been developed.
The technique is referred to as display cloning because it involves the cloning
of proteins displayed on the surface of a bacteriophage particle. The approach
has been established by isolating a full-length gene clone of FKBP12 (FK506-
binding protein) from a human brain cDNA library using a biotinylated FK506
probe molecule. During the affinity selection, the FKBP12 gene emerged as the
dominant library member and was the only sequence identified after the second
round of selection. 
Conclusions: The development of display cloning greatly facilitates the
investigation of ligand–receptor interaction biology and natural product mode of
action studies. This procedure utilizes heterologous protein display on
infectious phage, which allows the amplification and repeated selection of
putative sequences, leading to unambiguous target identification. In addition,
the direct connection of a functional protein to its gene sequence eliminates the
subsequent cloning step required with tissue homogenate or cell lysate affinity
methods, allowing direct isolation of an expressible gene sequence.
Introduction
Natural products have historically played an important role
in the elucidation of biological mechanisms [1–4]. The
identification of a natural product’s receptor provides an
important link between its phenotype and cellular compo-
nent [5–7]. The combination of in vitro genetic expression
techniques with traditional biochemical approaches, such
as affinity chromatography, offers the possibility of func-
tional gene selection by bridging natural product affinity
directly with gene structure. Phage display is one such in
vitro technique that allows the expression, selection and
subsequent amplification of proteins on the surface of bac-
teriophage viral particles, effectively linking a phenotype
to its genotype [8–10]. Complementary DNA (cDNA) is
the reverse transcriptase product of mRNA and represents
the coding sequence of all transcribed genes at the time of
mRNA isolation. By incorporating cDNA into phage
display, it is possible to obtain an expressible transcript of
every gene from any desired cell type. Many techniques
for the construction of double-stranded cDNA from
mRNA are available [11,12], and these procedures are so
advanced that it is possible to extract and construct a
cDNA library from a single cell [13]. Although several
cDNA phage display systems have been described, includ-
ing M13 pIII display [14–24], M13 pVI display [25] and
tailed bacteriophage display [26–29], these systems have
only been used to elucidate protein–protein interactions.
The use of nonpeptidic small molecule probes to identify
receptor proteins has remained elusive. In fact, it has been
postulated that the small molecule epitope may be too
small for use in phage display screening [30]. 
Display cloning is a method for the concomitant identifica-
tion and isolation of natural product protein cellular targets,
using a T7 cDNA phage display library and a biotinylated
natural product probe. Validation of this procedure was
obtained by using a T7 cDNA phage display library and
biotinylated FK506 as a natural product affinity probe. The
FK506–FKBP (FKBP; FK506 binding protein) interaction
is a challenging proof of principle for two reasons. First, the
carboxyl terminus of the protein is directly adjacent to the
middle strand of a five-strand β sheet [31,32], making it
difficult to remove the STOP codon in the cDNA tran-
script while maintaining an active fold. Second, FKBP12 is
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a cytosolic protein and therefore not efficiently secreted
through the periplasm of the bacterial cell wall. Both of
these criteria are required for M13 display [10]. Display
cloning utilizes T7 phage display, which overcomes these
difficulties. With biotinylated FK506 as a natural product
probe this procedure provided a single cDNA clone con-
taining the entire FKBP12 gene sequence after only two
rounds of affinity selection. An optimized protocol is pre-
sented, as well a discussion of the potential benefits of
combining in vitro genetic techniques with affinity chro-
matography as a general approach for the investigation of
small molecule ligand–receptor interactions.
Results and discussion
The display cloning procedure is shown schematically in
Figure 1. The protocol begins with the immobilization of
the biotinylated natural product onto a monomeric-avidin
agarose gel. The gel is utilized in a column and the cDNA
phage are allowed a single pass over the column. This is
followed by extensive washing to minimize any nonspe-
cific binding interactions between the phage coat proteins
and the agarose column. Phage that display proteins with
specific affinity for the natural product probe will remain
on the column during the wash step. These phage are
then selectively eluted with excess biotin. After elution,
the phage are rescued by immediate re-infection into
Escherichia coli and amplified. This cycle represents one
round of affinity selection and takes approximately eight
hours. The amplified phage can either be used in an addi-
tional round of selection or the selected protein(s) can be
analyzed by isolating and sequencing the phage DNA.
The procedure requires either a biotinylated natural
product or natural product affinity matrix and a cDNA
phage display library.
The most useful option for probe derivatization for FK506
was biotinylation, as opposed to the construction of a cova-
lent affinity matrix. After affinity purification, this same
probe could be used for the quantitative analysis of affinity
(Kd) and/or protein detection (western blot). Biotinylated
natural product also offers the feature of a reversible solid-
support reagent when combined with monomeric-avidin
sepharose. The synthesis of FK506–biotin (4) is outlined in
Figure 2 and starts with bis-silylated N-Boc-hexanedi-
amine-FK506 (1) [33–35]. Simultaneous deprotection of
the silyl groups and the Boc function of 1 with hydrofluoric
acid in 7:1 acetonitrile:water gave FK506-amine 2. Imme-
diate treatment of this nucleophilic amine with N-hydroxy-
succinimide–long-chain–biotin (NHS–LC–biotin) led to
formation of FK506–biotin (4). The biotin component of
compound 4 will serve as an anchor to the column resin,
whereas the FK506 component is free to interact with the
bacteriophage cDNA library.
Monomeric avidin bound to agarose was chosen as the
optimal solid-phase resin. It has a significantly lower
affinity for biotin (Kd ~10–7 M) enabling the selective
release of any biotin-bound species [36]. The elution is
specific for phage bound to the column through the
FK506–biotin interaction and is independent of the
natural product–target interaction because the entire
complex is eluted as a whole. This anchor-specific elution
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Figure 1
Display cloning procedure for one round of
affinity selection using a biotin-probe-treated
monomeric avidin column and cDNA phage.
At the end of the first round of selection, the
amplified phage can either be analyzed by
DNA sequencing or directly subjected to
additional round(s) of selection.
Incubate cDNA phage
with affinity column Elute with
biotin
Reinfect
E. coli
Amplify
phage
Column wash
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will allow the procedure to be generalized for any recep-
tor–ligand complex, regardless of off rate, allowing even a
covalent interaction to be efficiently eluted. More impor-
tantly, the elution conditions are mild, thus lowering the
possibility that nonspecifically bound phage will also be
removed. This is important because nonspecific interac-
tions in bacteriophage selections are well documented
[10]. The agarose column does provide an increase in
surface area, which increases the number of phage that
can be evaluated, but this can also lead to high back-
ground phage titers and a loss of signal amplification with
increasing selection rounds. The anchor-specific elution
reduces the number of nonspecific phage eluted, and as
long as the background interactions remain constant and
weak, even low abundance clones with high natural
product affinity will be selected for and become the dom-
inant members of the population after affinity maturation.
The choice of phage is crucial for cDNA incorporation.
Tailed phage alleviate two of the major problems encoun-
tered with M13 expression of cDNA libraries, namely the
STOP codon problem and protein secretion. The T7 bac-
teriophage display system is readily available, exhibits
rapid growth and was therefore selected for this study
[26]. Incorporation of cDNA into the traditional M13
phagemid is problematic because of the presence of a
STOP codon in the cDNA insert, which is amino-terminal
in this phage display fusion. This prevents the expression
of a complete insert-pIII fusion protein that is required for
display on the surface of the phage particles. Solutions for
the incorporation of cDNA into an M13 system have been
described [14,15,17,25,37], but even proteins that remain
functional must be secreted through the periplasmic space
of the bacterial cell wall in order to be properly displayed
on M13 phage [10]. Although this is likely to benefit pro-
teins that are normally secreted, such as antibodies and
membrane-bound receptors, it will provide a selective bias
against most cytosolic and nuclear localized proteins, and
will hamper affinity selection. Several examples of cDNA
libraries in M13 display systems are known [19–21,23,24],
but at this point none has been described for the study of
small molecule ligand–receptor interactions. In fact, these
reasons are probably why our attempts to utilize M13
cDNA display systems [25,37] did not lead to identifica-
tion of the target gene when probed with FK506.
A human brain cDNA library was cloned into bacterio-
phage T7 [26]. Construction of the directionally cloned,
randomly primed cDNA library was performed with
polyA+ purified mRNA from human brain. The new
cDNA library was directionally cloned using EcoRI and
HindIII restriction sites, then packaged in vitro and
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Synthesis of the biotinylated FK506 (4) probe molecule. (i) HF, CH3CN, H2O, rt (ii) pyridine, rt.
infected into E. coli to yield 3.3 × 106 transformants, based
on phage titer. The fusion of the gene encoding coat
protein 10 (cp10) and the cDNA insert allows one cDNA
protein product to be presented on the surface of each
phage particle (Figure 3a). As the cDNA insert is carboxy-
terminal to the coat protein (cp10), expression of the intact
fusion is not affected by the presence of a STOP codon.
Figure 3b shows a schematic of the T7-phage particle with
the displayed protein fused to the phage head, leaving the
tail free for E. coli infectivity. A small aliquot of the stored
human brain cDNA library was used to generate the
phage employed in the FK506 selection by inoculating a
log phase culture of E. coli. On average, T7 bacteriophage
production yields a titer of 1010 pfu/ml. By inoculating one
liter of culture with approximately 107 phage, a total of
1013 phagemids are formed. As the cDNA library contains
106 distinct transformants, each clone is represented by
approximately 107 phage particles.
Three 1ml affinity columns were prepared: the mono-
meric avidin column alone, a biotin pretreated column and
a column treated with FK506–biotin. In the first round of
selection phage supernatant (100 ml; ~1012 phage) was
poured over each 1ml column. The columns were sub-
jected to washing with 100 ml phage wash buffer (PWB:
1 × phosphate-buffered saline (PBS), 450 mM NaCl,
0.05% Tween20) followed by 10 ml dH2O. The bound
phage were eluted with a biotin solution (5 mM in PWB)
and collected in 0.5ml aliquots. Figure 4 shows a plot of
phage titer as a function of elution. As evidenced by the
elution titer (Figure 4a), quite a few cDNA proteins have
inherent affinity for the avidin binding sites on the
column. This is not unexpected because certain peptides
have been shown to bind the avidin protein [38]. These
interactions can, however, be suppressed by biotin pre-
treatment of the column (Figure 4b). It is useful to evalu-
ate the phage titer for at least the first selection because
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Figure 3
Schematic representation of the T7 display
vector and graphic diagram of coat protein
fusion to the expressed cDNA insert. (a) The
cDNA library is directionally cloned using
EcoR I and Hind III restriction sites. Efficient
surface expression of all clones is achieved,
regardless of the presence of a STOP codon
in the cDNA transcript, because the cDNA
insert follows the coat protein (cp10).
(b) Graphic representation of bacteriophage
T7 and the cp10 coat fusion with cDNA
protein product. The fusion takes place on the
phage head, leaving the neck and tail free for
E. coli infectivity.
cDNA Insertcp10
Stop
codon
T7 gene T7 gene
EcoR I Hind III
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Figure 4
Elution titers used for the evaluation of the
FK506/cDNA phage affinity selection. Phage
titers are evaluated as the last wash (typically
100× column volume) and the first few biotin
elutions. (a) Monomeric avidin alone (red)
shows the ability to bind cDNA-phage, as is
seen by the spike in titer with the biotin-
containing elution fractions. (b) When the
column is preincubated with biotin (yellow),
the column does not show appreciable titer
with specific elution. (c) Incubation with
FK506–biotin (4) restores retention of titer,
which extends over many more elutions than
the avidin alone. The elution is anchor
specific, suggesting that a specific interaction
is taking place between the biotin–FK506 and
members of the cDNA phage library. 
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this can be an indication of both the level of background
phage–column interaction and of an affinity interaction.
The FK506–biotin treated column showed an elevated
titer, relative to the biotin control, suggesting a strong
interaction between FK506 and members of the cDNA
library (Figure 4c).
The eluted phage aliquots from the first FK506–biotin
column selection round were combined and infected into
log phase E. coli. The resulting amplified phage were then
subjected to a second round of selection. After each round,
five random phage plaques were selected for analysis. As
T7 genomic DNA is quite large (39 kb), analysis of insert
size was performed by polymerase chain reaction (PCR)
amplification of the insert region using primers designed
to anneal to the vector sequence flanking the cloning site
(Figure 5a). Although this procedure results in a band with
118 base pairs (bp) more than the gene insert, it does allow
rapid monitoring of the progress of the selection at each
round. By comparing the relative size of each band, the
number of identical clones may be inferred. This is useful
information because an affinity selection should produce
one or more clones that dominate the phage population
after several rounds of selection.
One of the most remarkable features of display cloning
with the natural product FK506 was the rapidity with
which target selection took place. Random analysis of the
phage library prior to the first selection showed no redun-
dant clones in the library (Figure 5b). In addition, no
duplicate sequences were noted after the first round of
selection. However, one of the clones identified in the
first round became the dominant clone in the second
round, giving a band size of 450 bp. By the second round
of selection this was the only clone detected in the phage
population. A BLAST [39] search of the DNA sequence
obtained for this clone revealed sequence identity to the
FKBP12 gene, the known cellular target of FK506
[40–42]. Figure 6 shows the gene sequence for the iso-
lated clone. The gene was obtained in its fully expressible
form, as observed by the presence of 5′- and 3′-untrans-
lated region (UTR) as well as START and STOP codons,
flanked by the EcoRI and HindIII cloning sites. The effi-
ciency of this selection is probably related to the high
affinity that FK506 has for FKBP12 (Kd = 0.4 nM) [43]. It
remains to be seen what level of affinity is required for
target identification. In principle, a small molecule with
micromolar affinity would also be amenable to this tech-
nique, but may require more than two rounds of selection.
Several FKBP homologs have been reported [1–2]. As
display cloning is selective in nature, it provided the
highest affinity and smallest protein in the FKBP family.
Modification of this procedure to screen for additional
binding proteins might include DNA sequencing of
clones from earlier selections and/or additional affinity
rounds after DNA-level subtraction of the dominant
clone, in this case FKBP12.
Advantages of affinity chromatography with cDNA phage
display 
One of the major benefits of display cloning is the ease
with which consecutive rounds of selection can be
employed, because the phage retain their infectivity. This
allows for an iterative protocol, leading to an amplification
of signal, which is important when probing cDNA libraries
for low abundance genes. In addition to signal amplifica-
tion, the competition for the natural product, in this case
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Figure 5
PCR analysis of amplified phagemids after
each selection round. (a) Primers annealing to
the vector sequence allow the amplification of
a band corresponding to the size of the insert
+118 bp of vector sequence. In addition to
size analysis, this amplified sequence can be
also used for DNA sequencing and/or
subcloning. (b) PCR band-size analysis of
selected clones. The clones analyzed prior to
the affinity selection show a wide range of
sizes (five out of 20 shown). After the first
round of selection, the evaluated clones and
appeared to have a diverse representation.
The second-round phage all gave the same
band size and were found to be identical by
DNA sequencing. It should be noted that no
FKBP gene was isolated prior to selection.
During the course of library construction and
evaluation, 35 independent clones were
isolated and sequenced without the
identification of the FKBP gene.
Gene
T7-up
T7-down
5′-UTR 3′-UTR T7 genome
T7 genome
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FK506, provided a selective pressure between the clones
in the cDNA phage library and allowed the unambiguous
assignment of FKBP12 as the affinity target of FK506,
because it was the only phage in the population after affin-
ity maturation. When display cloning is used for natural
products for which the cellular target is unknown, the
evaluation of earlier selection rounds may prove useful for
the identification of additional binding proteins and/or
smaller binding domains within the target protein.
Many methods for identifying receptor–ligand complexes
have been developed, including cell screening [44], bio-
chemical elucidation [45,46], affinity chromatography
[40,47–54], and more recently mRNA expression arrays
[55–57]. All of these methods require that the gene
sequence for the target protein must either be inferred
from the screen or peptide sequenced from an isolated
protein, with subsequent cloning of the identified gene.
To circumvent the need for a subsequent cloning step,
many gene-linked methods for analyzing small mol-
ecule–protein interactions have been described [58–63],
and one has even been applied to natural product target
elucidation [61]. These cell-based methods have inherent
limitations such as requiring the spatial segregation of
cells as well as the solubility and membrane permeability
of the natural product probes. This can lead to either a
low signal or the use of a large quantity of precious
natural product. Indeed, even with the availability of
these methods, affinity chromatography remains the pre-
dominant approach for natural product mode of action
studies [52–54].
In vitro techniques that incorporate cDNA in an express-
ible format offer direct access to gene products. Expression
cloning is one example that takes advantage of the link
between gene and expression product, allowing the
cloning of a desired gene directly from a cDNA library
[64,65]. This technique is based on an antibody’s affinity
for the target protein or a nucleotide’s affinity for its
Watson–Crick complement. Although peptides [66], nucle-
oside derivatives [67] and a drug–BSA (bovine serum
albumin) conjugate [68] have been used with expression
cloning, a natural product interaction has not been
reported. One potential explanation for this may be that,
like the cell-based methods, expression cloning requires a
direct signal readout, is not readily amenable to affinity
amplification, and is therefore limited by probe solubility
and availability. Alternate in vitro techniques, designed to
link genotype with phenotype, have been described and
include: phage display [8–10], plasmid display [69,70],
polysome display [71,72], protein tagging [73], in vitro
expression cloning (IVEC) [74], ribosome display [75–77],
RNA-fusion display [78], baculoviral display [79], bacterial
cell-surface display [80,81] and eukaryotic cell-surface
display [82]. Although not all of these systems are
amenable to the incorporation of cDNA libraries, they have
the benefit of signal amplification and the ability to
perform multiple selection rounds, bypassing the signal
sensitivity problem. Affinity chromatography could, in
principle, be combined with any of these methods to estab-
lish novel functional cloning procedures.
Tailed phage systems, such as T7, are emerging as a
viable alternative to M13 bacteriophage display; several
have recently been described [26,83–87] and a number of
examples incorporate cDNA libraries [26–29]. The tailed
phage are inherently superior to the M13 phage for cDNA
expression because many involve expression at the car-
boxyl terminus of the surface fusion. Tailed phage are also
lytic. As M13 phage are secretory, displayed proteins must
be secreted through the periplasmic space of E. coli.
Although this is possible, it does transfer a selective
advantage to those proteins that are inherently membrane
associated or endogenously expressed for extracellular
localization. Tailed phage burst the cell membrane upon
maturation and therefore no selective advantage is con-
ferred through protein characteristics. Additionally, cell
lysis is able to provide cell-based cofactors (i.e. DNA,
RNA, additional proteins, and so on) that may also be
involved in the affinity complex. This would be most
useful in ligand–receptor systems where more than one
cellular component may be required for activity [88].
Affinity chromatography offers the benefit of evaluating
many potential protein interactions at once, because all
available proteins can be applied to the solid support simul-
taneously [89]. Traditional approaches involve the use of
either tissue homogenate or cell lysate for the production of
the natural receptor. This requires the homogenization of
many kilograms of animal tissue or, in the case of cell
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Figure 6
Sequence analysis of the isolated phage clone. Sequence analysis
reveals that the FKBP12 gene is in frame with the capsid protein cp10,
as required for expression. A segment of 5′-UTR (untranslated region)
is observed, followed by an open reading frame, the FKBP12 gene
sequence and finally a short 3′-UTR segment. No poly A tail is present
because the library was constructed using random primers. Three
silent mutations were noted in the sequence (underlined bases) which
is the only difference between the sequence we identified and those
previously described [41,42,95].
GGT GTG ATG CTC GGG GAT CCG AAT TCA GGA GAT ATA CAT ATG GGC
capsid gene10B EcoR I 5′-UTR START
T7 vectorHind III3′-UTRSTOP
GTG CAG GTG GAG ACT ATC TCC CCA GGA GAC GGG CGC ACC TTC CCC
AAG CGC GGC CAG ACC TGC GTG GTG CAC TAC ACC GGG ATG CTT GAA
GAT GGA AAG AAA TTT GAT TCC TCC CGG GAC AGA AAC AAG CCC TTT
AAG TTT ATG CTA GGC AAG CAG GAG GTG ATC CGA GGC TGG GAA GAA
GGG GTT GCC CAG ATG AGT GTG GGT CAG AGA GCC AAA CTG ACT ATA
TCT CCA GAT TAT GCC TAT GGT GCC ACT GGG CAC CCA GGC ATC ATC
CCA CCA CAT GCC ACT CTC GTC TTC GAT GTG GAG CTT CTA AAA CTG
GAA TGA CAGGAATGGCCTCCTCCCTTAAGCTTGCGGCCGCACTCGAGTAAC
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lysates, culturing many liters of mammalian cells [90]. Once
the receptor has been identified, the procedure is scaled up
and the protein is isolated and purified to homogeneity in
order to chemically determine its protein sequence. Subse-
quent database queries allow the identification of genes
that encode known proteins or expressed sequence tags
(ESTs) [39]. This sequence information is then used to
probe cDNA libraries for the genetic clone [91].
Display cloning combines the benefit of gene-linked in
vitro protein display with the power of affinity chromatog-
raphy to provide direct access to the human genes of
natural product receptors. The technique also has the
potential to identify even the least abundant genes,
because it employs a selective amplification, therefore
bypassing the need for cDNA library normalization [92].
This is crucial because it is estimated that between 50,000
and 100,000 different genes are transcribed across all
eukaryotic cell types and between 10,000 and 30,000 are
expressed in any one cell type [93]. In addition, because
the total number of phage that display cloning can evalu-
ate extends beyond 1012 particles, it is possible to envision
large libraries of cDNA gene fragments that would
increase the potential of identifying natural product
binding domains within a target protein.
Conclusions and future work
We have described a cDNA-phage-based system for the
elucidation of small molecule–receptor interactions,
leading directly to the genetic element of the target
protein. More complex display systems offer the hope of
achieving expression conditions that will provide proper
folding and post-translational modifications. It also remains
to be shown whether membrane-associated proteins can be
displayed in this manner. It is likely that these problems
will require the use of eukaryotic display systems such as
baculoviral [79] or mammalian [82] systems.
The link between nucleic acid sequence and protein func-
tion is one that nature has surely made from its beginning
[94]. Our understanding of the relationship between
genome structure and function will depend on our ability
to rediscover this link and probe it with natural products.
Future experiments will involve efforts to query these
systems with protein display of cDNA libraries. Display
cloning can be used in conjunction with natural products
and combinatorial chemical libraries for the exploration of
functional genomics.
Significance
Display cloning is a new method for the in vitro analysis
of receptor–ligand interactions, directly from cDNA.
The cellular target of FK506 is well defined. We have
shown that this cytosolic target can be functionally dis-
played and affinity selected in an in vitro system. The
validation of a small molecule epitope for the functional
cloning of a gene target has been established and will
serve as a starting point for additional efforts in natural
product target elucidation. The ability to probe natural
diversity with a natural product probe, leading to the
direct identification of the target gene, will greatly
enhance natural product mode of action studies. The
power of combining affinity chromatography with a
gene-linked system is that, in theory, any cell type in any
phase of cell cycle or growth can be targeted. This will
prove important in the exploration of teratogenic natural
products to identify proteins important to organismal
development, particularly because of the inherent limita-
tion of human fetal tissue and the potential lack of devel-
opmentally important proteins in mature animal tissue.
Materials and methods
Synthesis of FK506–biotin (4)
To a solution of Boc-FK506-TBS2 (7.5 mg, 5.8 µmol) [34] in 250 µl 7:1
CH3CN:H2O was added to 50 µl 48% HF in an Eppendorf tube. The
solution was allowed to stir at room temperature until all of the starting
material was consumed and ninhydrin staining revealed the presence
of an amine with low Rf (0.1 in 31.1 ml t-butylacetate, 15.7 ml glacial
acetic acid, 6.0 ml n-butanol and 14.4 ml water). Upon addition of
NHS-LC-biotin (3.3 mg, 5.8 µmol; Pierce Chemical Company, Rock-
ford, IL) the ninhydrin spot immediately disappeared and a new spot
with a slightly higher Rf appeared. The reaction was quenched with sat-
urated sodium bicarbonate (250 µl), extracted with methylene chloride
(3 × 500 µl) and dried over sodium sulfate. The crude mixture was sub-
jected to column chromatography (from 9:1 to 4:1, CH2Cl2:MeOH)
and provided 1.7 mg (5.8 µmol) of FK506–biotin (4) (Rf 0.1 in 9:1
CH2Cl2:MeOH) in 35% yield.
Construction of human brain cDNA phage library
Bovine brain has traditionally been a good tissue source for the FKBP
protein [40]. As display cloning only requires a small amount of mRNA
for library construction, human brain was chosen as the mRNA source.
Purified human brain poly A+ mRNA (obtained from normal whole cere-
bral brain tissue of a 50 year old Caucasian male, Clontech, Inc., Palo
Alto, CA) was randomly primed in the first-strand synthesis followed by
second-strand synthesis to yield double-stranded complimentary DNA.
The cDNA was doubly digested with EcoRI and Hind III endonucleases
and size fractionated. The purified cDNA was then directionally ligated
into T7Select1-1b vector arms and subsequently in vitro packaged into
phagemids (Novagen, Madison, WI). Ligation efficiencies were evalu-
ated with a small aliquot of the packaged phage and indicated a total of
3.3 × 106 plaque forming units. These initial transformants were sub-
jected to one amplification step by infecting 50 ml log phase BLT5403
cells, providing a human brain library of cDNA phage with an overall
titer of 3.6 × 1010 pfu/ml. The library was stored in aliquots (100 µl) at
–78°C as 8% glycerol stocks.
Generation of cDNA phage for library selection
To one liter of 2 × YT culture was added BLT5403 cells (from a 1 ml
saturated culture) and incubated at 37°C until cell growth reached log
phase (OD600 = 0.5–0.8). The culture was then inoculated with 10 µl
(9 × 108 phage) of the human brain cDNA library stock described
above. The number of phage used was 200-fold over the original
library diversity in order to maintain an appropriate representation of all
library members. It is estimated that there are 2.0 × 108 cells/ml in a
culture at OD600 = 0.5. The level of infectivity (LOI) is kept above 1000
(LOI = # cells/# of phage) in order to ensure complete infection. This
is important since a liquid culture amplification was performed. The
culture was incubated at 37°C until completely lysed. To achieve high-
salt conditions of the phage supernatant, 100 ml of 5 M NaCl was
added and the suspension centrifuged at 4700 rpm for 20 min at 4°C
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in order to precipitate the cell debris. This supernatant solution had a
final library titer of 1.8 × 1010 pfu/ml and was used directly in the affin-
ity selections described below.
Affinity chromatography with biotinylated FK506 and cDNA
phage
Three 1 ml aliquots of monomeric avidin resin (ImmunoPure Immobi-
lized Monomeric Avidin Gel, Pierce Chemical Company, Rockford, IL)
were incubated with (i) PWB, (ii) 5 mM biotin in PWB and
(iii) FK506–biotin (4) with slow rotation for 30 min at 4°C. All three
columns were then rinsed with PWB (30 ml). The cDNA phage super-
natant (100 ml) was poured over each column, followed by washing
with PWB (100 ml) and distilled water (10 ml). The elution step for
each column was identical and involved treatment with 10 ml of 5 mM
biotin and collecting the eluate in 0.5 ml aliquots. A small amount
(10 µl) from each fraction was used for titer determination (Figure 5).
The fractions from the FK506 selection were combined and used to
inoculate 100 ml of log phase BLT5403 cells and incubated at 37°C
until completely lysed. After lysis, 10 ml of 5 M NaCl was added and
the solution centrifuged at 4700 rpm for 20 min at 4°C to precipitate
the cell debris. The supernatant contains the amplified phage from the
first selection, however, it still has approximately 0.5 mM biotin from the
previous elution. The biotin was removed through precipitation of the
phage by adding 80 ml phage precipitant (33% PEG-8000, 3.3 M
NaCl) and centrifuging at 7000 rpm for 10 min at 4°C. The precipitated
phage were resuspended in 30 ml PWB, and a small amount (5 ml)
was stored at –78°C as an 8% glycerol stock. An FK506–biotin affinity
column was prepared as described above and the remaining 25 ml of
the amplified phage were poured over the column. The column was
washed with PWB (100 ml) and distilled water (10 ml), then eluted
with 5 mM biotin (10 ml). The eluate for both the first and second
selection rounds were plated onto 2 × YT top agar and single plaques
were selected for DNA analysis.
Evaluation and sequencing of cDNA inserts
Individual plaques, 20 prior to selection and five from each round of
selection, were stabbed and used to inoculate log phase cultures of
BLT5403 cells (10 ml) and allowed to incubate at 37°C until the
culture completely lysed. Genomic DNA was isolated from the phage
supernatants using standard lambda DNA purification resin (Wizard
Lambda Preps DNA Purification System, Promega Corp., Madison,
WI). Two primers, T7-up (5′-GGAGCTGTCGTATTCCAGTC-3′) and
T7-down (5′-AACCCCTCAAGACCCGTTTA-3′) anneal to the vector
sequence immediately flanking the cloning site and were used with
standard PCR conditions to evaluate the relative size of the insert
region of the isolated clones (Figure 4). As all of the clones from the
second round of selection appeared to have the same insert size, they
were subjected to DNA sequencing and were subsequently found to
be identical clones (Figure 6). Sequencing reactions were performed
with the T7-up primer using fluorescently labelled dideoxynucleotides
and Taq FS DNA polymerase in a thermal cycling protocol, and were
analyzed on an Applied Biosystems 377 DNA Sequencer.
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